This mutation leads to a reduction in the MTHFR enzyme activity (1–3), resulting in impaired folate metabolism and an accumulation of homocysteine in the body, causing hyperhomocysteinemia. The gene discussed is MTHFR; the disease is hyperhomocysteinemia.